Evidence map›Paper›PMID 40677518›Full record

ArticleDigital health

An exercise prescription algorithm for clinicians to use with their patients with cardiovascular disease risk factors.

Shiqi Chen, Yin Wu, Justin Kennedy, Gregory Panza, Margaux Zwierko Guidry, Linda S Pescatello, FACSM

Registry-linked trialAbstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07238556 (Feasibility and Acceptability of a Novel Algorithm for Physicians to Prescribe Personalized Exercise Prescriptions to Patients With Cardiovascular Disease Risk Factors), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07238556 narecruitingnot on this map

Feasibility and Acceptability of a Novel Algorithm for Physicians to Prescribe Personalized Exercise Prescriptions to Patients With Cardiovascular Disease Risk Factors: Study Protocol for an Exploratory Randomized Controlled Crossover Trial

TypeinterventionalSponsorUniversity of ConnecticutRan2026 to 2026Enrolled72ConditionsHypertension, Dyslipidemia, Diabetes Mellitus, ObesityArmsExperimental - 12 Week P3-EX Unsupervised Exercise Program with Virtual Weekly Oversight from Graduate Research Assistants, Active Control - 12 Week ACSM-PAVS Unsupervised Exercise Program with Virtual Weekly Oversight from Graduate Research Assistants
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shiqi ChenDepartment of Kinesiology, University of Connecticut, Storrs, CT, USA.ORCID https://orcid.org/0009-0000-7190-462X
Yin WuDepartment of Research Design and Support, Hartford Hospital, Hartford, CT, USA.
Justin KennedySonalysts, Inc., Waterford, CT, USA.
Gregory PanzaHartford HealthCare Research Administration, Hartford, CT, USA.
Margaux Zwierko GuidryServier Pharmaceuticals, Boston, MA, USA.
Linda S PescatelloDepartment of Kinesiology, University of Connecticut, Storrs, CT, USA.
FACSM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Half of US adults have ≥1 cardiovascular disease (CVD) risk factors. Exercise is the first-line lifestyle therapy to prevent and treat CVD. We developed the Prioritize Personalize Prescribe Exercise algorithm (P3-EX), an evidence-based tool that clinicians can use to prescribe exercise for patients with CVD risk factors. Purpose: To conduct a feasibility survey study of user satisfaction and usability of P3-EX as an exercise prescription (ExRx) tool among healthcare providers. Methods: Healthcare providers enter information on the patient's medical history and CVD risk factors into P3-EX. Prioritize Personalize Prescribe Exercise algorithm then scores and prioritizes CVD risk factors and produces an ExRx for the prioritized CVD risk factor. We recruited physicians ( Results: Of the 844 recruited participants, 309 completed the feasibility survey study (healthcare provider N = 143, people with other professional affiliates N = 166). Of these, 86.9% agreed using P3-EX will make their patients healthier; 86.6% agreed feedback is immediate and understandable; 81.4% agreed P3-EX is intuitive, producing high-quality, evidenced-based, individualized ExRx; 83.5% are generally satisfied with P3-EX; 81.3% would recommend P3-EX to colleagues; and 79.2% agreed ExRx produced by P3-EX is safe. However, 34.4% agreed fault tolerance could be improved. Most participants (88.8%) produced an ExRx for the same prioritized CVD risk factor. The average time spent using P3-EX was 4.6 min. Conclusion: We found healthcare providers are satisfied with P3-EX and agreed that it is a usable ExRx tool for patients with CVD risk factors. Our results are promising because healthcare providers lack the time, knowledge, confidence, and guidance to recommend exercise to patients. Prioritize Personalize Prescribe Exercise algorithm appears to be a potential solution to this problem.

Indexed as

appscardiovascular diseasechronicdiabetesDigital healthexercisehypertensionlifestyleobesityrisk factors

Identifiers

PMID40677518
PMCPMC12268123

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.